Intestinal Research

IBD
Anti-inflammatory diet and inflammatory bowel disease: what clinicians and patients should know?: Nor Hamizah Shafiee, Zahara Abdul Manaf, Norfilza M. Mokhtar, Raja Affendi Raja Ali; Intest Res. 2021;19(2):171-185. Published online February 3, 2021; DOI: https://doi.org/10.5217/ir.2020.00035
Web of Science 19 Crossref 18; Full text PubReader ePub PDF

Long-term efficacy and tolerability of dose-adjusted thiopurine treatment in maintaining remission in inflammatory bowel disease patients with NUDT15 heterozygosity: Takato Maeda, Hirotake Sakuraba, Hiroto Hiraga, Shukuko Yoshida, Yoichi Kakuta, Hidezumi Kikuchi, Shogo Kawaguchi, Keisuke Hasui, Tetsuya Tatsuta, Daisuke Chinda, Tatsuya Mikami, Shinsaku Fukuda; Intest Res. 2022;20(1):90-100. Published online January 22, 2021; DOI: https://doi.org/10.5217/ir.2020.00133
Web of Science 8 Crossref 7; Full text PubReader ePub PDF Supplementary Material

Inflammatory Bowel Diseases
Efficacy and safety of vedolizumab in Crohn’s disease in patients from Asian countries in the GEMINI 2 study: Rupa Banerjee, Sai Wei Chuah, Ida Normiha Hilmi, Deng-Chyang Wu, Suk-Kyun Yang, Dirk Demuth, Dirk Lindner, Shashi Adsul; Intest Res. 2021;19(1):83-94. Published online December 31, 2020; DOI: https://doi.org/10.5217/ir.2019.09160
Web of Science 16 Crossref 16; Full text PubReader ePub PDF Supplementary Material

Efficacy and safety of vedolizumab in ulcerative colitis in patients from Asian countries in the GEMINI 1 study: Choon Jin Ooi, Ida Normiha Hilmi, Hyo-Jong Kim, Umesh Jalihal, Deng-Chyang Wu, Dirk Demuth, Dirk Lindner, Shashi Adsul; Intest Res. 2021;19(1):71-82. Published online September 4, 2020; DOI: https://doi.org/10.5217/ir.2019.09159
Web of Science 16 Crossref 17; Full text PubReader ePub PDF Supplementary Material

Ustekinumab for the treatment of refractory pediatric Crohn’s disease: a single-center experience: Alexandra Cohen, Najma Ahmed, Ana Sant’Anna; Intest Res. 2021;19(2):217-224. Published online April 22, 2020; DOI: https://doi.org/10.5217/ir.2019.09164
Web of Science 6 Crossref 8; Full text PubReader ePub PDF

Inflammatory bowel diseases
Tacrolimus for ulcerative colitis in children: a multicenter survey in Japan: Tadahiro Yanagi, Kosuke Ushijima, Hidenobu Koga, Takeshi Tomomasa, Hitoshi Tajiri, Reiko Kunisaki, Takashi Isihige, Hiroyuki Yamada, Katsuhiro Arai, Atsushi Yoden, Tomoki Aomatsu, Satoru Nagata, Keiichi Uchida, Yoshikazu Ohtsuka, Toshiaki Shimizu; Intest Res. 2019;17(4):476-485. Published online August 31, 2019; DOI: https://doi.org/10.5217/ir.2019.00027
Web of Science 10 Crossref 8; Full text PubReader ePub PDF Supplementary Material

IBD
Remission of diffuse ulcerative duodenitis in a patient with ulcerative colitis after infliximab therapy: a case study and review of the literature: Yong-Sung Choi, Jong Kyu Kim, Wan Jung Kim, Mi-Jung Kim; Intest Res. 2019;17(2):273-277. Published online February 12, 2019; DOI: https://doi.org/10.5217/ir.2018.00122
Web of Science 4 Crossref 7; Full text PubReader ePub PDF

Association of endoscopic and histological remission with clinical course in patients of ulcerative colitis: Vikram Narang, Ravneet Kaur, Bhavna Garg, Ramit Mahajan, Vandana Midha, Neena Sood, Ajit Sood; Intest Res. 2018;16(1):55-61. Published online January 18, 2018; DOI: https://doi.org/10.5217/ir.2018.16.1.55
Web of Science 60 Crossref 60; Full text PubReader ePub PDF

A Case of Cronkhite-Canada Syndrome Showing Spontaneous Remission: Dong-Uk Kang, Dong-Hoon Yang, Yunsik Choi, Ji-Beom Kim, Ho-Su Lee, Hyo Jeong Lee, Sang Hyoung Park, Kee Wook Jung, Kyung-Jo Kim, Byong Duk Ye, Jeong-Sik Byeon, Seung-Jae Myung, Suk-Kyun Yang, Jin-Ho Kim; Intest Res. 2013;11(4):317-322. Published online October 30, 2013; DOI: https://doi.org/10.5217/ir.2013.11.4.317
Crossref 1; PDF

Search